Azetidines
OA: closed
AI-generated summary
This invention describes azetidines acting as EP2 antagonists, their synthesis intermediates, and compositions for treating endometriosis and uterine fibroids.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
The invention relates to EP2 antagonist azetidines of formula (I) wherein Ar, R, X, and Z are as defined herein, to their use in medicine, particularly in the treatment of endometriosis and/or uterine fibroids, to intermediates useful in their synthesis, and to compositions containing them.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- europepmc
- last seen: 2026-10-14T06:08:39.101224+00:00